Amnestic mild cognitive impairment: Diagnostic outcomes and clinical prediction over a two-year time period
Amnestic mild cognitive impairment (MCI) has been defined as a precursor to Alzheimer's disease (AD), although it is sometimes difficult to identify which persons with MCI will eventually convert to AD. We sought to predict MCI conversion to AD over a two-year follow-up period using baseline de...
Gespeichert in:
Veröffentlicht in: | Journal of the International Neuropsychological Society 2006-03, Vol.12 (2), p.166-175 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Amnestic mild cognitive impairment (MCI) has been defined as a
precursor to Alzheimer's disease (AD), although it is sometimes
difficult to identify which persons with MCI will eventually convert to
AD. We sought to predict MCI conversion to AD over a two-year follow-up
period using baseline demographic and neuropsychological test data from 49
MCI patients. Using a stepwise discriminant function analysis with
Dementia Rating Scale (DRS) Initiation/Perseveration and Wechsler
Memory Scale, third edition (WMS-III) Visual Reproduction Percent
Retention scores, we correctly classified 85.7% of the sample as either AD
converters or MCI nonconverters, with 76.9% sensitivity and 88.9%
specificity. Adding race, the presence of vascular risk factors, or
cholinesterase inhibitor use to the analysis did not greatly change the
classification rates obtained with neuropsychological test data. Examining
neuropsychological test cutoff scores revealed that DRS
Initiation/Perseveration scores below 37 and Visual Reproduction
Percent Retention scores below 26% correctly identified AD converters with
76.9% sensitivity and 91.7% specificity. These results demonstrate that
commonly administered neuropsychological tests identify persons with MCI
at baseline who are at risk for conversion to AD within 1–2 years.
Such methods could aid in identifying MCI patients who might benefit from
early treatment, in providing prognostic information to patients, and
identifying potential clinical trial participants. (JINS, 2006,
12, 166–175.) |
---|---|
ISSN: | 1355-6177 1469-7661 |
DOI: | 10.1017/S1355617706060267 |